NCT00818597View on ClinicalTrials.gov

Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

April 30, 2004

Study Completion Date

June 30, 2008

Conditions
Severe Sepsis and Septic Shock
Interventions
DEVICE

EISS

Two six hour-treatments with the EISS-Immune-cell bioreactor device within 72 hours post inclusion.

Trial Locations (1)

18055

University of Rostock, Department of Medicine, Division of Nephrology, Rostock

All Listed Sponsors
lead

University of Rostock

OTHER

NCT00818597 - Extracorporeal Immune Support System (EISS) for the Treatment of Septic Patients | Biotech Hunter | Biotech Hunter